InspireMD (NSPR) Convertible Debt (2010 - 2012)

InspireMD's (NSPR) quarterly Convertible Debt came in at $5.6 million in Q3 2012, up 12.3% quarter-over-quarter from $5.0 million in Q2 2012.

InspireMD (NSPR) Convertible Debt (2010 - 2012) Analysis & Trends

InspireMD's Convertible Debt history runs 2 years deep, the most recent figure standing at $5.6 million for Q3 2012.

On a quarterly basis, Convertible Debt changed N/A year-over-year to $5.6 million in Q3 2012; TTM through Sep 2012 was $5.6 million, a N/A change from a year earlier, with the FY2012 full-year figure at $5.0 million, changed N/A from the prior year.
Convertible Debt rose to $5.6 million in Q3 2012 per NSPR's latest filing, from $5.0 million in the prior quarter.
Across five years, Convertible Debt topped out at $5.6 million in Q3 2012 and bottomed at $1.0 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	InspireMD	2,073.45	-54.21 Mn	1.18 Mn

Download Data